Rating Change
Citizens analysts initiated coverage on Annexon, Inc. (NASDAQ:ANNX) with a Market Underperform rating on July 21, 2026.
new coverageNASDAQ:ANNX
Citizens Initiates Coverage on Annexon, Inc. (ANNX) with Market Underperform
Rating Change Citizens analysts initiated coverage on Annexon, Inc. (NASDAQ:ANNX) with a Market Underperform rating on July 21, 2026. Market Context Annexon, Inc.
Market Context
Annexon, Inc. operates in the Healthcare sector. The stock currently trades at $5.44 with a market capitalization of $669.7M.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Annexon, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Annexon, Inc.
Among the 10 most recent ratings: 8 Buy, 1 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | Citizens | Market Underperform | N/A |
| Jul 15, 2026 | Needham | Buy | N/A |
| May 12, 2026 | Goldman Sachs | Neutral | N/A |
| Mar 20, 2026 | Chardan Capital | Buy | N/A |
| Dec 23, 2025 | Chardan Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ANNX Stock Page
Frequently Asked Questions
What does a Market Underperform rating mean for ANNX?
A Market Underperform rating from Citizens reflects the analyst's outlook on Annexon, Inc. (NASDAQ:ANNX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ANNX forecast page.